i dont think ill be changing any positions any time soon, im set for awhile.
i dont think ill be changing any positions any time soon, im set for awhile.
I was looking at (F) Ford this evening. I think it is a really great long. Their financials or O.K. and they aren't holding out a tin cup and begging for money. That might be a move for me pretty ricky ticky.
You're all set up now.....I would just hang and watch and maybe pick up some other one, but basically you are in the groove, dude.![]()
Scary looking. You could live a life time between trades. Between trades, evolution could progress and you might look down and have six toes. I just got rid of a sleeper this morning. It only has one to two trades an hour. It did spike though, I see what grabbed your attention.
i get all kinds of alerts from ameritrade, it was in my volume above average alert, not too many on there so this one stuck out. just wondering if it still has legs or not, seomthing is obviously going on. This is the only news i could find on it atm from ameritrade.
Angiotech's corporate partner, Boston Scientific, announces Japanese approval for TAXUS(R) Liberte(R) drug-eluting stent system
8:30a ET January 29, 2009 (PR NewsWire)
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, today announced that its corporate partner, Boston Scientific Corporation (NYSE: BSX), has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its TAXUS(R) Liberte(R) paclitaxel-eluting coronary stent system. Boston Scientific plans to launch the product in Japan once reimbursement approval is granted. The TAXUS Liberte was approved by the FDA in October 2008 and was launched in Europe and several other international markets in 2005.
"The TAXUS Liberte stent is the latest advance in drug-eluting stent technology for Japan," said Donald Baim, M.D., Chief Medical and Scientific Officer of Boston Scientific. "Its safety and efficacy have been well demonstrated in multiple clinical studies and years of clinical use."
"We are pleased to see the approval of TAXUS Liberte in Japan as it demonstrates our partner's commitment to expanding its international acceptance," said Dr. William Hunter, President and CEO of Angiotech. "Japanese patients and their families struggling with coronary artery disease should soon be able to benefit from this proven technology."
TAXUS Liberte is the only second-generation drug-eluting stent approved for use in Japan. The TAXUS Liberte stent will replace the TAXUS Express(2)(TM) stent, marketed in Japan since May 2007. Significant design improvements over the first-generation stent include thinner struts and a more uniform stent geometry.
I have a studio in my basement where me and my 13 year old daughter tear it up...I have Vintage Westbury electric and my daughter has 2 electric gutairs her first Austin and now a Epiphone Les Paul. Then we have a no name short neck base... We have a Peavey Renown 400 amp and also a TNT 100 base amp..I also have a peavey xr 680E 8 input powered mixer with 2 vintage earth Speakers which I run my 2 wireless mics and a pearl Drum-X
programmable electronic drums set with Zildjian crash, sabian crash and paiste highhat... I have a Yamaha 6 string, Aria 12 string and a Dean Acustic
Base with a built in pick up. And last a Young Chang student upright piano and a yamaha psr-225gm keyboard....I am a old school Rock & Roller, I play some Stones, Sabbath, Lou Reed, Eagles and what ever else pops in my head..n the base I play some Schooldays by Stanley Clark which is progressive jazz..
I learned to play by ear so Im limited....My daughter shes good.. she plays alot of new stuff and some old but she reads music and records on garage band on her mac...she plays the star spangle banner and her new guitar teacher already has her helping him teach in class....I guess we all have alot in common!![]()
It is an important product. The first second generation stent since 2007. It has a real application.
I now remember, I saw this on my favorite stock blogger site this evening. Maybe the word out will give it momentum for a run. Here is what he wrote:
Hot Penny Stocks:
Angiotech Pharmaceuticals ( ANPI ) - $0.45 Up 25% - Angiotech's corporate partner, Boston Scientific, announces Japanese approval for TAXUS(R) Liberte(R) drug-eluting stent system.
What do you think?
if it starts up tommorow morning as well you might do well jumping in and riding it out. Im out of peso's atm though and i dont want to sell anything elseas i get seller's remorse lol